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We demonstrate that a Rho kinase inhibitor (Y-
27632), in combination with fibroblast feeder cells,
induces normal and tumor epithelial cells from many
tissues to proliferate indefinitely in vitro, without
transduction of exogenous viral or cellular genes. Pri-
mary prostate and mammary cells, for example, are
reprogrammed toward a basaloid, stem-like pheno-
type and form well-organized prostaspheres and
mammospheres in Matrigel. However, in contrast to
the selection of rare stem-like cells, the described
growth conditions can generate 2  106 cells in 5 to 6
days from needle biopsies, and can generate cultures
from cryopreserved tissue and from fewer than four
viable cells. Continued cell proliferation is dependent
on both feeder cells and Y-27632, and the condition-
ally reprogrammed cells (CRCs) retain a normal
karyotype and remain nontumorigenic. This tech-
nique also efficiently establishes cell cultures from
human and rodent tumors. For example, CRCs estab-
lished from human prostate adenocarcinoma dis-
played instability of chromosome 13, proliferated ab-
normally in Matrigel, and formed tumors inmice with
severe combined immunodeficiency. The ability to
rapidly generate many tumor cells from small biopsy
specimens and frozen tissue provides significant op-
portunities for cell-based diagnostics and therapeu-
tics (including chemosensitivity testing) and greatly
expands the value of biobanking. In addition, theCRC method allows for the genetic manipulation of
epithelial cells ex vivo and their subsequent evalu-
ation in vivo in the same host. (Am J Pathol 2012, 180:
599–607; DOI: 10.1016/j.ajpath.2011.10.036)
The unlimited propagation of adult mammalian, nonkera-
tinocyte epithelial cells offers exciting opportunities for
gene and cell-based therapies, as well as regenerative
and personalized medicine. However, it has not been
possible to passage and rapidly expand cells derived
from adult glandular tissues that retain lineage commit-
ment and normal growth and differentiation potential. This
has been particularly problematic, for example, with cells
derived from the prostate, lung, and liver (either normal or
neoplastic) and has severely limited their in vitro charac-
terization.1,2 The propagation of adult epithelial cells re-
quires specialized medium and is limited by the early
onset of senescence. Although it is possible to bypass
this senescence block using viral oncogenes, such as
SV40 large T antigen3 or the E6/E7 proteins of the onco-
genic human papillomaviruses,4–8 the resultant cell lines
have aberrant p53 and Rb regulatory pathways. It is also
possible to immortalize primary human adult cells with
exogenous human Telomerase reverse transcriptase
(hTERT) and additional cellular genes, such as cdk4,9 but
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hTERT alone have disrupted differentiation, as assayed
by mammosphere formation in Matrigel. In addition,
some somatic cells can be reprogrammed and ex-
panded into induced pluripotent stem (iPS) cells.10–15
Although iPS techniques extend cell life span, this
method is relatively inefficient and uses the transduc-
tion of exogenous genes that can induce alterations in
the cellular genome16–18 and antigenicity.19,20 Also,
precise control of the fate of iPS cells is still undergoing
experimental refinement. To date, it has not been pos-
sible to continuously propagate adult epithelial cells in
culture without permanently compromising their normal
phenotype.
Recently, we established a method to indefinitely ex-
tend the life span of primary human keratinocytes using
both fibroblast feeder cells and a Rho-associated kinase
(ROCK) inhibitor, Y-27632.21 However, the culture of
nonkeratinocytes has proved to be difficult over the
years, and feeder cells are not generally used to culture
these cells. There are synthetic media (without feeders)
that can generate limited populations of some nonkerati-
nocyte cells, but none that can induce unrestricted pro-
liferation. Indeed, some human epithelial cells, such as
prostate, lung, and liver, have extremely short in vitro life
spans and can only be passaged for a few times before
they cease proliferation.1,2,9,22–25 This limited prolifera-
tion is also characteristic of primary human cancers, such
as those derived from the prostate.2 Interestingly, the
principal prostate cancer cells available for research
have been derived from aggressive metastatic tumors.
Later, we describe a widely applicable tissue culture
method that rapidly and conditionally reprograms normal
and tumor epithelial cells to a highly proliferative state
during which they maintain their original karyotypes. As
shown previously with keratinocytes, removal of these
conditions restores the capacity for cell differentiation.
We speculate on a potential mechanism that is operative
in the generation of these conditionally reprogrammed
cells (CRCs).
Materials and Methods
Harvesting of Tissues
Normal or tumor human mammary/prostate specimens
were collected with the informed consent of the patients,
according to Georgetown University Institutional Review
Board (Washington, DC) protocols. Mammary tissues
were minced and digested with a mixture of dispase and
collagenase 1A (StemCell Technologies Inc, Vancouver,
BC, Canada), and fat was removed with a cell strainer (70
m; BD Biosciences, Bedford, MA). Prostate tissues
were chopped into 1-mm fragments and digested with
trypsin. In addition to cells derived from tissue, we also
obtained primary normal epithelial cells (human mam-
mary epithelial cell, herein called mammary, and human
prostate epithelial cell, herein called prostate) from Lonza
(Walkersville, MD) and tracheal/bronchial lung cells from
Lifeline (Lifeline Cell Technology, Walkersville, MD).Hepatocytes were harvested using a two-step collage-
nase perfusion technique. Briefly, liver tissues were first
perfused with calcium and magnesium-free Hanks’ buffer
at 80 to 100 mL/minute for 10 to 15 minutes; the second
perfusion was performed with 0.5 g/L collagenase solu-
tion at 50 to 70 mL/minute for 10 minutes. The two per-
fusion steps were performed at 37°C to 38°C. After per-
fusion, the liver capsule was incised. The thick fibrous
connective tissue was discarded, and cell suspensions
were harvested. The cell suspensions were further di-
gested at 37°C for 10 to 15 minutes. RPMI 1640 medium
was used for cessation of digestion, and the released
cells were filtered through three-layer sterilized gauze
and washed by three centrifugations (50  g).
Cryopreservation of Human Tissue
Fresh human breast tissue from a patient who underwent
reduction mammoplasty was minced into small pieces or
thin slices with a maximal size of 1 to 3 mm. The tissue
pieces were then frozen in cryopreservation medium
[90% fetal calf serum (Invitrogen, Gaithersburg, MD)/10%
dimethyl sulfoxide (v/v; Sigma-Aldrich, St. Louis, MO) 5
mol/L Y-27632 (Enzo Life Sciences, Lausen, Switzer-
land)] at 80°C or in liquid nitrogen. At later times, the
frozen tissue was thawed at 37°C, pelleted, and sus-
pended in F medium for a brief digestion with dispase-
collagenase (StemCell). The cell suspensions were sub-
jected to the culture system, as described later.
Cell Culture
Two different culture conditions were used to propagate
both commercially available and harvested epithelial
cells in standard tissue culture flasks.1 The primary
method of epithelial cell propagation used a fibroblast
feeder cell system.26 Epithelial cells were cocultivated
with irradiated (3000 rad) Swiss 3T3 fibroblasts (J2 strain)
in F medium [3:1 (v/v) F-12 Nutrient Mixture (Ham)–Dul-
becco’s modified Eagle’s medium (Invitrogen), 5% fetal
bovine serum, 0.4 g/mL hydrocortisone (Sigma-Al-
drich), 5 g/mL insulin (Sigma-Aldrich), 8.4 ng/mL chol-
era toxin (Sigma-Aldrich), 10 ng/mL epidermal growth
factor (Invitrogen), and 24 g/mL adenine (Sigma-Al-
drich)] with addition of 5 to 10 mol/L Y-27632 (Enzo Life
Sciences). All cells were maintained at 37°C in a humid-
ified incubator, with 5% CO2, and passaged at a 1:4
(cells without feeder fibroblasts) or a 1:8 to 1:32 (cells
with feeder fibroblasts) split ratio when 80% to 90% con-
fluent. The growth curves were plotted as population
doublings versus time (days).21 Mammary, prostate,
and lung cells were also grown in defined media [mam-
mary epithelial growth medium and prostate epithelial
growth medium (PrEGM) from Lonza and keratincytes
growth medium from Invitrogen] without serum.
Separation of Feeder and Epithelial Cells
Differential trypsinization was used to separate feeder
and epithelial cells during passaging. Briefly, feeder/ep-
ithelial co-cultures were rinsed with PBS and incubated
Reprogramming of Epithelial Cells 601
AJP February 2012, Vol. 180, No. 2with 0.05% trypsin solution at room temperature for 30
seconds to 1 minute, with close monitoring by phase
microscopy. When the feeder cells rounded up and be-
gan to detach from the substrate, the cultures were gently
tapped and the detached cells were removed by aspira-
tion. The epithelial colonies remained tightly adherent.
The epithelial cells were rinsed again with PBS and then
retrypsinized at 37°C for 3 to 5 minutes. After gentle
pipetting to disperse the epithelial cells into a single-cell
suspension, the cells were pelleted through PBS contain-
ing 10% serum (to neutralize trypsin). After centrifugation
at 500  g, the cell pellets were resuspended in F me-
dium for passaging or in cryopreservative medium (see
previous description) for freezing.
Transduction of Mammary Epithelial Cells with
Myc and hTERT
Human primary mammary epithelial cells were trans-
duced with the Myc T58A or hTERT genes, and cell lines
were established by continued passaging, as described
in a previous publication.22
Three-Dimensional Culture
Single-cell suspensions of epithelial cells were dispersed
into serum-free keratinocyte growth medium (Invitrogen)
containing 2% Matrigel (BD Biosciences). Morphogene-
sis assays (and the harvesting of acini, immunostaining,
and confocal microscopy) were performed as previously
described.27,28
Real-Time RT-PCR
Total RNA was extracted using an RNeasy kit (Qiagen,
Valencia, CA). Total RNA, 1 g, was reverse transcribed
in 20 L of reaction mixture using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA). Quantitative real-time PCRs containing
100 ng of total cDNA were performed using TaqMan
Gene Expression Assays (Applied Biosystems) on the
Applied Biosystems 7900HT Fast Real-Time PCR System
using fast mode. The assay identification numbers of the
validated genes were as follows: androgen receptor,
Hs00171172_m1; NK3 homeobox 1, Hs00171834_m1;
and prostate stem cell antigen, Hs04177224_g1. Ampli-
fication of human -actin mRNA (4310881E) was used as
an endogenous control to standardize the amount of
sample added to the reaction. To obtain relative values,
the following arithmetic formula was used: 2CT, where
CT  difference between the threshold cycles of the
target and an endogenous reference (-actin mRNA).
The real-time PCR conditions were as follows: 1 cycle at
90°C for 20 minutes, then 40 cycles at 95°C for 1 second,
and 60°C for 20 seconds. Assays consisted of three
technical replicates. hTERT mRNA was measured using
the methods and primers that have been previously pub-
lished.29,30Immunofluorescence Staining
Cells were grown on sterile glass coverslips and fixed in
4% (w/v) paraformaldehyde, permeabilized with 0.1% sa-
ponin in PBS containing 0.2% gelatin, and labeled with
the primary (mouse anti-p63; Santa Cruz Biotechnolo-
gies, Santa Cruz, CA, sc-863) and secondary (Alexa
Fluor 488 donkey anti-mouse IgG; Invitrogen) antibody,
according to the manufacturer’s protocol. DNA in the
cells was stained for 3 minutes at room temperature with
0.5 g/mL Hoescht (number 33342) in PBS and washed
three times with PBS. Coverslips were mounted on glass
slides using ProLong anti-fade mounting medium (In-
vitrogen) for 1 hour at room temperature and were
stored at 4°C. A Zeiss Axioskop microscope (Carl
Zeiss, Inc., Thornwood, NY), equipped with a 63
objective lens and a Hammamutsu charge-coupled de-
vice camera, was used to image the cells. Images were
processed using Openlab software version 3.0.7 (Im-
provision, Coventry, UK).
Conventional Cytogenetic Analysis
Prostate cells at passage 33 were cultured, and chromo-
somes were prepared and G-banded using standard
protocols.31 Chromosomes were identified and classified
according to standard cytogenetic nomenclature.32
STR Analysis
Short tandem repeat (STR) analysis (ie, DNA fingerprint-
ing) was performed using a commercially available kit
(Cell ID System; Promega Corporation, Madison, WI).
This system allows the co-amplification and three-color
detection of 10 loci (nine STR loci and the Y-chromo-
some–specific Amelogenin). This approach provides a
powerful level of discrimination of approximately 2.92 
109. The following STR markers were tested in addition to
the Amilogenin locus: CSF1PO, TPOX, TH01, vWA,
D21S11, D16S539, D7S820, D13S317, and D5S818. The
PCR amplification was performed according to the manu-
facturer’s recommended protocol and as previously de-
scribed.33 Detection of the amplified fragments was
achieved with the ABI 3100 genetic analyzer (Applied
Biosystems). Data analysis and allele size determination
were performed using GeneMapper Software (Applied
Biosystems).
Xenograft Assays
Exponentially growing normal or tumor prostate cells (1
106) were trypsinized, dispersed into single cells, and
suspended in 200 L of Matrigel HC (BD Biosciences).
The Matrigel-suspended cells were injected s.c. into the
left and right flanks of 6-week-old male imprinting control
region mice with severe combined immunodeficiency
(Taconic, Germantown, NY). The growth of xenografts
was measured weekly with calipers. Animals were
housed at the Georgetown University animal care facility,
according to institutional guidelines.
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Samples of normal or tumor tissue were collected with
the informed consent of the patients, according to
Georgetown University Institutional Review Board pro-
tocols. All animal experimental procedures were re-
viewed and approved by the Institutional Animal Careand Use Committees of Georgetown University Medi-
cal Center.
Results
Figure 1A describes the technique for establishing CRCs
from normal and neoplastic human epithelium. An Insti-
tutional Review Board–approved protocol was used to
obtain biopsy specimens or samples of fresh surgical
specimens in the Department of Pathology, Georgetown
University Hospital. The samples were dispersed into
single cells by digestion with collagenase/trypsin (see
Materials and Methods), and the cells were plated in me-
dium containing irradiated Swiss 3T3 J2 cells26 and 5 to
10 mol/L Y-27632. Epithelial colonies were readily ob-
served at 2 days and rapidly proliferated to reach con-
fluence in approximately 5 days. Examples of human
Figure 1. Propagation and immortalization of human adult epithelial cells.
A: Prostate, breast, tracheal, and liver (hepatocellular carcinoma) tissues
were harvested and digested with trypsin-collagenase, as described in Ma-
terials and Methods. Cells isolated from the tissues were plated on a feeder
layer of irradiated (3000 rad) Swiss 3T3 cells (J2 subclone) and grown in F
medium containing 10 mol/L ROCK inhibitor (Y-27632). Small colonies
could be observed after 1 day. At day 5 (shown), there were large islands of
epithelial (epi) cells that compressed the surrounding feeder cells (white
arrows). B: The prostate and breast epithelial cells were passaged repeti-
tively using trypsinization techniques described for keratinocytes.21 The cell
number was recorded at each passage, and a plot of population doublings
versus time (days) was constructed. The cells were grown under four differ-
ent conditions: with both feeder cells and Y-27632 in F medium, with feeders
only in F medium, with Y-27632 in mammary epithelial growth medium or
PrEGM or mammary epithelial growth medium or PrEGM alone. Only cells
Table 1. Tissues Used for Cell Isolation and Culture
Species Tissue type Cases
Total
samples
Cell
lines
Normal/
diseased
Human Breast 13 25 25 18/4B/3T
Prostate 9 16 16 9/7T
Lung 6 8 8 5/3T
Liver 5 6 3 1/2T
Colon 4 8 4 1/4T
Pancreas 5 8 4 2/2T
Endothelium 1 1 1 1/0
Ovary 1 1 1 1/0
Pancreas (met) 1 1 1 0/1T
Oral (H&N) 2 3 3 1/2T
Mouse Breast 7 7 7 6/1T
Prostate 3 3 3 3/0
Rat Breast 5 5 5 1/4T
Dog Skin epithelium 1 1 1 1/0
Oral epithelium 1 1 1 1/0
Total NA 64 94 83 NA
The tissues for which biopsy specimens were obtained for culture are
indicated for each of the mammalian species. The number of cases (patient
or animal) is indicated, as is the total number of samples taken from those
cases. The cell lines that were generated from these samples are also
indicated, and the success rate was determined by dividing the number of
generated cell lines by the total number of samples placed into tissue culture.
The success rate is defined as the ability of the cultured cells to reach 50
population doublings or, in some cases (colon and pancreas), as three times
the population doublings observed with current, optimal culture conditions.
B, BRCA1/2 mutation carrier; H&N, head and neck cancer; met, met-
astatic; NA, not applicable; T, tumor.grown in F medium containing feeders and Y-27632 continued to proliferate
with a constant growth rate.
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cinoma) colonies are shown. Mouse and rat CRC cultures
have also been established successfully from primary
breast, prostate, and liver tissue using an identical pro-
tocol (see Supplemental Figures S1 and S2 at http://
ajp.amjpathol.org).34,35 The average success rate of es-
tablishing CRCs is approximately 88% from a variety of
animal tissues, although some tissues exhibit 100% suc-
cess rates (Table 1).
After the first plating, the breast CRCs in Figure 1A
were passaged every 3 days at 1:4 to 1:8 dilutions and
the prostate cells were passaged at 1:16 to 1:32 dilutions,
verifying the robust growth of these epithelial cultures.
When plated at single-cell densities, colony-forming effi-
ciency varied from 40% to 70%. However, when cells
were passaged at a normal density (eg, 1:16 splits), there
was no morphological evidence of cell death. The rapid
reprogramming of normal adult epithelial cells to a pro-
liferative state is consistent with their expression of p63, a
marker of basal cell phenotype (see Supplemental Figure
S3 at http://ajp.amjpathol.org).To determine the contributions of feeder cells and
Y-27632 to the exuberant growth of nonkeratinocyte CRCs,
we assayed the growth kinetics of human mammary and
prostate cells under different culture conditions (Figure 1B).
Both cell types proliferated continuously in F medium con-
taining feeder cells and Y-27632. The growth of the prostate
cells was particularly rapid, with the culture reaching 120
population doublings in 120 days. As shown, continuous
cultures could not be initiated with either breast or prostate
cells using F medium and feeder cells without Y-27632. In
addition, breast and prostate cells grown in commercial
medium designed for these cells (mammary epithelial
growth medium and PrEGM, respectively; Lonza) became
senescent at early times, either in the presence or absence
of the ROCK inhibitor. Finally, cells cultured in F medium
alone (containing neither feeders nor Y-27632) immediately
ceased proliferation and underwent rapid terminal differen-
tiation, due in part to the serum and higher calcium levels
present in the F medium. Thus, both feeder cells and
Y-27632 were necessary for the highly efficient, long-term
Figure 2. Characterization of late-passage breast and pros-
tate cells. A: The differentiation potential of prostate and
breast cells was evaluated by culture in Matrigel, without
feeders or Y-27632, as described in Materials and Methods.
Both prostate and breast cells formed normal prostaspheres
(A, top row, left panel) and mammospheres (A, top row,
second panel from left) with glandular lumens. The mam-
mospheres showed normal polarized laminin deposition
around the periphery of the sphere (A, bottom row, left
panel). In addition, the mammospheres also showed the
characteristic cytoplasmic/plasma membrane localization of
-catenin observed in normal epithelial cells (A, bottom
row, second panel from left, green). In contrast, mam-
mary cells immortalized with the Myc T58A mutant showed
abnormal differentiation and formed abnormally shaped
solid spheres with extensions into the Matrigel (A, top row,
second panel from right). Scale bars: 25 m (white); 20
m (yellow). These Myc-immortalized cells also exhibited
abnormal deposition of laminin within the sphere and with-
out polarized localization to the colony periphery (A, bot-
tom row, second panel from right). Mammary cells im-
mortalized by hTERT also formed abnormal solid spheres (A,
top row, right panel) with aberrant, dispersed distribution
of laminin (A, bottom row, right panel). B: The cause of
the high hTERT expression in the epithelial cells is the result
of the in vitro culture conditions. When prostate cells are
grown in commercial medium (PrEGM), the level of hTERT
mRNA is low. However, when those cells are transferred to
F medium with feeders (with or without Y-27632), there is an
approximate 20-fold increase in hTERT expression. The
greatest impact is the presence of feeder cells. C: Induction
of hTERT mRNA in breast and prostate cells is similar and
occurs early during passaging. Quantitative real-time PCR for
hTERT was performed at the indicated passage numbers.
Both cell types show an early induction of telomerase ex-
pression. In prostate, for example, the induction is maximal
already at passage 2, indicating that selection during in vitro
culture is not the cause of this induction. D: Chromosomal
analysis of late-passage prostate cells revealed a normal
46,XY karyotype. E: DNA fingerprinting of early- and late-
passage prostate cells demonstrated that they have nine
identical STR loci and the Y-specific Amelogenin locus,
thereby verifying their genetic identity. Data are presented as
mean  SEM.establishment of cell cultures from primary tissue.
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late-passage mammary and prostate CRCs continued to
proliferate (at least for limited doublings) when trans-
ferred to Matrigel (in keratincytes growth medium) in the
absence of these two components. In Matrigel, they
formed well-defined prostaspheres and mammospheres
(Figure 2A). The mammospheres were characterized by
a well-defined cell/Matrigel interface and showed polar-
ized synthesis of laminin that surrounded each colony
(Figure 2A). In addition, the mammospheres expressed
-catenin in the cytoplasm and adjacent to plasma mem-
branes (Figure 2A), typical for normal epithelial cells.
Lumen formation was observed in both prostaspheres
and mammospheres and is best illustrated in cells
stained with -catenin. In contrast, mammary cells that
were transformed by a Myc mutant (T58A)22 formed solid
masses of disorganized colonies with extensions into the
Matrigel, a characteristic of transformed or tumorigenic
cells (Figure 2A). Corresponding to this morphological
alteration, laminin deposition by the cells was not polar-
ized to the cell/Matrigel interface, but was dispersed in
the sphere (Figure 2A). Similarly, mammary cells that were
immortalized by hTERT (but not transformed as defined by
growth in agarose) formed aberrant Matrigel colonies con-
sisting of solid masses (Figure 2A) with generalized, non-
polarized accumulation of laminin (Figure 2A).
Telomerase plays a critical role in primary cell immor-
talization, and our initial studies indicated that feeder
cells induced pronounced telomerase activity and hTERT
expression in keratinocytes.21,29 To determine whether
hTERT induction was also observed in nonkeratinocytes,
we quantified hTERT mRNA in prostate cells in medium
with and without feeders and Y-27632 (Figure 2, B and
C). Prostate cells grown in F medium with feeders or
feeders plus Y-27632 exhibited a 20-fold increase in
hTERT expression compared with cells grown in syn-
thetic PrEGM medium (Figure 2B). Mammary cells also
exhibited a similar induction of hTERT expression levels
when propagated on feeder cells (Figure 2C). We nextexamined whether the late-passage CRCs from normal
tissues retained a diploid karyotype. The results for pros-
tate cells (at population doubling 93) are shown in Figure
2D and verify that their chromosomes are structurally and
numerically normal, with a 46,XY karyotype. The breast
cells were also normal by karyotype analysis (46,XX; X.L.,
B.R.H, R.S., unpublished data). To verify that our immor-
talized CRC cultures were not contaminated with another
cell line during prolonged passaging, we performed DNA
fingerprinting analysis at nine STR loci and at the Y-spe-
cific Amelogenin locus (Cell ID System; Promega). The
data in Figure 2E demonstrate that the prostate cell cul-
tures, when analyzed at early and late passages, are
identical at all 10 loci, thus confirming their identity.
The ability to generate matched normal and cancer
cells from patients provides a renewable source for com-
parative genetic and biochemical analysis, as well as
drug screening. As an example, we obtained matched
biopsy specimens of normal and malignant prostate tis-
sue from the same patient and processed them as de-
scribed. By day 3 after plating, epithelial colonies had
already formed, expanded, and compressed adjacent
feeder cells (Figure 3). The growth rate and morpholog-
ical characteristics of the normal and tumor cells were
similar. However, the normal and tumor cells differed in
the expression of several markers. In tumors cells, the
androgen receptor and prostate stem cell antigen were
increased, whereas the NK3 homeobox 1 prostate tumor
suppressor protein was decreased (see Supplemental
Figure S4 at http://ajp.amjpathol.org). The normal and tu-
mor cells also displayed biological differences in three-
dimensional Matrigel cultures (Figure 3). The normal
prostate cells formed prostaspheres, as previously
shown in Figure 2A, whereas the tumor cells formed large
undifferentiated aggregates, similar to those observed for
breast cells transformed by Myc. The normal and tumor
cells could also be distinguished by xenograft assays.
When the normal and tumor prostate cells were sus-
Figure 3. Establishment of normal prostate and
prostate adenocarcinoma cell cultures from the
same patient. Biopsy specimens of normal and
malignant prostate tissue from the same patient
were processed and propagated in vitro, as de-
scribed in Materials and Methods. For two-di-
mensional cultures, cells were photographed at
days 2 and 3, demonstrating the rapid and equiv-
alent outgrowth of cells from the biopsy speci-
mens. For in vitro three-dimensional cultures,
matched cells were also grown in the three-
dimensional Matrigel system, as described in
Materials and Methods. The normal prostate
cells formed prostaspheres, whereas the tumor
cells formed large undifferentiated aggregates.
For an in vivo xenograft, 1 million normal and
tumor cells were injected s.c. into the flanks of
five mice with severe combined immunodefi-
ciency at two different sites (a total of 10 sites for
each cell type). The prostate cancer cells in-
duced tumors at 7 of 10 sites within 8 weeks; a
representative tumor is shown (arrow). The
normal prostate cells did not induce tumors (0 of
10 sites). epi, epithelial cells.pended in Matrigel and injected s.c. into mice with severe
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weeks) only in mice receiving the cells derived from pros-
tate cancer (Figure 3). Finally, there were also karyotype
differences between these two cell cultures. The karyo-
type of the prostate tumor cells exhibited instability of
chromosome 13 (X.L., R.S., unpublished data), in con-
trast to the normal karyotype of the matched normal pros-
tate cells. STR fingerprinting analysis verified that these
two prostate cell cultures were, indeed, derived from the
same patient (X.L., R.S., unpublished data).
We have also established CRC cultures from as few as
two to four viable cells (Figure 4), suggesting potential
applications to the study of circulating tumor cells. Per-
haps more important, we generated cell cultures from hu-
man tissues frozen in cryopreservative medium, a finding
that will affect the practice of pathology and biobanking
(see Supplemental Figure S5 at http://ajp.amjpathol.org).
Discussion
In contrast to current methods for culturing primary
epithelial cells or for inducing pluripotent stem cells
(iPS cells), establishing CRC cultures with feeders and
Y-27632 is rapid and efficient. For example, we have
generated 1  106 to 2  106 normal prostate cells
from a single mouse prostate in 6 days (see Supple-
mental Figure S1 at http://ajp.amjpathol.org) and 2 
106 breast carcinoma cells from a core biopsy speci-
men of a rat breast cancer in 5 days (see Supplemental
Figure S2 at http://ajp.amjpathol.org). We have also
demonstrated that cultured cells derived from breast
tumors of transgenic human epidermal growth factor
receptor 2/neu mice (Friend’s leukemia virus B strain)
induced tumors when injected into mammary fat padsof the same strain (data not shown). The ability to
generate matched normal and cancer cells from pa-
tients is a fundamental breakthrough in cell culture
technology. This system allows, for the first time to our
knowledge, the direct comparison of the molecular and
genetic profile of the normal and transformed epithelium,
enabling patient-specific ex vivo pathobiological analysis.
In addition, the ability to culture metastatic lesions will
enable identification of the cellular changes that occur
and potentially contribute to invasion and metastasis.
Figure 5. Potential model for the cooperative effects of F medium plus
feeders and the ROCK inhibitor in cell immortalization. Class 1 genes induce
telomerase activity, and class 2 genes alter both the p16/Rb pathway and the
Figure 4. Colony-forming efficiency of primary
human cells. Human keratinocytes and cervical
cancer cells (Caski) were plated at the indicated
cell numbers onto the feeder cell cultures. After
7 to 10 days, the feeder cells were removed and
the epithelial colonies were fixed for 5 minutes
with 3.7% paraformaldehyde, and then stained
for 30 minutes with 0.05% crystal violet. The
plates were photographed and the colonies
were counted with ChemiDoc and QuantityOne
software (Bio-Rad Laboratories, Inc, Hercules,
CA). A: The number of cells plated was plotted
versus the number of colonies observed after 7
to 10 days. B: The efficiency of colony formation
for the cervical cancer cells is depicted for the
indicated number of Caski cells plated. The plat-
ing efficiency for low-density seeding ranged
from 40% to 70%. Data are presented as mean 
SEM.cell cytoskeleton. The connecting lines indicate documented interactions
between class 1 and class 2 genes that result in cell immortalization.
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epithelial cells to a proliferative state with keratinocytes.21
Even epithelial cells that were entering a senescence
phase were immediately converted to a proliferative state
when transferred to F medium containing feeder cells
and Y-27632. These findings demonstrate that the com-
bination of feeder cells and Y-27632 is directly altering
cell growth, rather than selecting for a small subpopula-
tion of stem-like cells.24,25,36–40 The mechanism for this
reprogramming is unclear, although there are insightful
parallels with the process of cell immortalization induced
by the human papillomaviruses (Figure 5). The high-risk
human papillomaviruses encode two oncoproteins, E6
and E7, that are required for the efficient immortalization
of primary cells. One of the most critical roles for the E6
protein in cell immortalization is the induction of
hTERT.4,41,42 We have demonstrated that the predomi-
nant factor for hTERT induction in CRCs is growth in F
medium with feeder cells and that Y-27632 has a minimal
contribution to this induction. The mechanism by which
telomerase is induced by the F medium plus feeder cells
is under investigation.
The second component of human papillomavirus–me-
diated cell immortalization is the function of the E7 pro-
tein. In addition to its role in inactivating the Rb pathway,
E7 has recently remodeled the actin cytoskeleton43 and
inactivated Rho.44 Alterations of actin/myosin activity are
the main consequence of ROCK inhibition,45,46 and this
cytoskeletal network has a primary role in regulating cell
proliferation.45–48 It is also possible that Y-27632 is per-
turbing the p16 pathway, although our previous studies21
indicate that p16 expression is maintained under our
culture conditions. Overall, we believe that the combina-
tion of F medium containing feeder cells and Y-27632
supplies two distinct functions that promote unrestricted
cell proliferation: (1) induction of telomerase and (2) cy-
toskeletal remodeling and/or interference with the p16/Rb
pathway. In Figure 5, we have listed several cellular genes
that fall into these two designated pathways. The genes and
proteins in the first class (red box) have induced telomerase
activity, whereas the genes and the ROCK inhibitor that
compose the second class (blue box) modulate both
p16/Rb and/or perturb the cellular cytoskeleton. The inter-
connecting lines indicate functional pairs of cellular and/or
viral genes and inhibitors known to collaborate in cellular
immortalization.4,6,7,9,21,22,41,43,49–54
In conclusion, a critical finding in this study is that the
combination of feeder cells and ROCK inhibitor induces
continued cell proliferation without the use of exogenous
viral or cellular gene transduction. It is significant that this
reprogramming of cell growth and differentiation is con-
ditional, thereby allowing facile in vitromanipulation of cell
behavior. In addition, we have also observed that CRCs
immortalized by the feeder/ROCK system display a more
normal cellular phenotype than cells immortalized by
hTERT. Mammary CRCs, in contrast to hTERT-immortal-
ized cells, form mammospheres in Matrigel that exhibit a
well-defined cell-stroma interface and polarized localiza-
tion of laminin. The ability to rapidly generate CRCs from
both normal and tumor (or disease) tissue offers an ex-
citing opportunity to integrate live cell biology into thepractice of pathology. In addition, the efficiency and ro-
bust nature of establishing CRCs should greatly expand
the value of biobanking and provide an inexhaustible
supply of patient-specific cells for comparative genetic
and molecular analysis.
Acknowledgments
We thank Robert Clarke, Leena Clarke, Anni Warri, Mary
Beth Martin, Blair Marshall, and Ruth He for helpful dis-
cussions and for providing cell and tissue samples and
Janice D. Rone for technical assistance.
References
1. Castell JV, Gomez-Lechon MJ: Liver cell culture techniques. Methods
Mol Biol 2009, 481:35–46
2. Miki J, Rhim JS: Prostate cell cultures as in vitro models for the study
of normal stem cells and cancer stem cells. Prostate Cancer Prostatic
Dis 2008, 11:32–39
3. Van der Haegen BA, Shay JW: Immortalization of human mammary
epithelial cells by SV40 large T-antigen involves a two step mecha-
nism. In Vitro Cell Dev Biol 1993, 29A:180–182
4. Liu X, Dakic A, Chen R, Disbrow GL, Zhang Y, Dai Y, Schlegel R:
Cell-restricted immortalization by human papillomavirus correlates
with telomerase activation and engagement of the hTERT promoter by
Myc. J Virol 2008, 82:11568–11576
5. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT:
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin
keratinocytes. EMBO J 1989, 8:3905–3910
6. Hudson JB, Bedell MA, McCance DJ, Laiminis LA: Immortalization
and altered differentiation of human keratinocytes in vitro by the E6
and E7 open reading frames of human papillomavirus type 18. J Virol
1990, 64:519–526
7. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and
E7 genes of the human papillomavirus type 16 together are neces-
sary and sufficient for transformation of primary human keratinocytes.
J Virol 1989, 63:4417–4421
8. Schlegel R, Phelps WC, Zhang YL, Barbosa M: Quantitative keratino-
cyte assay detects two biological activities of human papillomavirus
DNA and identifies viral types associated with cervical carcinoma.
EMBO J 1988, 7:3181–3187
9. Roig AI, Eskiocak U, Hight SK, Kim SB, Delgado O, Souza RF,
Spechler SJ, Wright WE, Shay JW: Immortalized epithelial cells de-
rived from human colon biopsies express stem cell markers and
differentiate in vitro. Gastroenterology 2010, 138:1012–1021.e1011-
e1015
10. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from
mouse embryonic and adult fibroblast cultures by defined factors.
Cell 2006, 126:663–676
11. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K,
Yamanaka S: Induction of pluripotent stem cells from adult human
fibroblasts by defined factors. Cell 2007, 131:861–872
12. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F,
Vassena R, Bilic J, Pekarik V, Tiscornia G, Edel M, Boue S, Izpisua
Belmonte JC: Efficient and rapid generation of induced pluripotent
stem cells from human keratinocytes. Nature Biotechnol 2008, 26:
1276–1284
13. Yamanaka S, Blau HM: Nuclear reprogramming to a pluripotent state
by three approaches. Nature 2010, 465:704–712
14. Okita K, Yamanaka S: Induced pluripotent stem cells: opportunities
and challenges. Philos Trans R Soc Lond B Biol Sci 2011, 366:2198–
2207
15. Unternaehrer JJ, Daley GQ: Induced pluripotent stem cells for mod-
elling human diseases. Philos Trans R Soc Lond B Biol Sci 2011,
366:2274–2285
16. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J,
Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD,
Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF,
Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ,
Reprogramming of Epithelial Cells 607
AJP February 2012, Vol. 180, No. 2Goldstein LS, Zhang K: Somatic coding mutations in human induced
pluripotent stem cells. Nature 2011, 471:63–67
17. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, Ng
S, Sourour M, Hamalainen R, Olsson C, Lundin K, Mikkola M, Trokovic
R, Peitz M, Brustle O, Bazett-Jones DP, Alitalo K, Lahesmaa R, Nagy
A, Otonkoski T: Copy number variation and selection during repro-
gramming to pluripotency. Nature 2011, 471:58–62
18. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosie-
wicz-Bourget J, O’Malley R, Castanon R, Klugman S, Downes M, Yu
R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR: Hotspots of
aberrant epigenomic reprogramming in human induced pluripotent
stem cells. Nature 2011, 471:68–73
19. Taylor CJ, Bolton EM, Bradley JA: Immunological considerations for
embryonic and induced pluripotent stem cell banking. Philos Trans R
Soc Lond B Biol Sci 2011, 366:2312–2322
20. Zavazava N: Immunity of embryonic stem cell-derived hematopoietic
progenitor cells. Semin Immunopathol 2011, 33:613–617
21. Chapman S, Liu X, Meyers C, Schlegel R, McBride AA: Human
keratinocytes are efficiently immortalized by a Rho kinase inhibitor.
J Clin Invest 2010, 120:2619–2626
22. Thibodeaux CA, Liu X, Disbrow GL, Zhang Y, Rone JD, Haddad BR,
Schlegel R: Immortalization and transformation of human mammary
epithelial cells by a tumor-derived Myc mutant. Breast Cancer Res
Treat 2009, 116:281–294
23. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS,
Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON:
Human prostate sphere-forming cells represent a subset of basal
epithelial cells capable of glandular regeneration in vivo. Prostate
2010, 70:491–501
24. Terunuma A, Limgala RP, Park CJ, Choudhary I, Vogel JC: Efficient
procurement of epithelial stem cells from human tissue specimens
using a Rho-associated protein kinase inhibitor Y-27632. Tissue Eng
Part A 2010, 16:1363–1368
25. Zhang L, Valdez JM, Zhang B, Wei L, Chang J, Xin L: ROCK inhibitor
Y-27632 suppresses dissociation-induced apoptosis of murine pros-
tate stem/progenitor cells and increases their cloning efficiency.
PLoS One 2011, 6:e18271
26. Rheinwald JG, Green H: Serial cultivation of strains of human epider-
mal keratinocytes: the formation of keratinizing colonies from single
cells. Cell 1975, 6:331–343
27. Debnath J, Muthuswamy SK, Brugge JS: Morphogenesis and onco-
genesis of MCF-10A mammary epithelial acini grown in three-dimen-
sional basement membrane cultures. Methods 2003, 30:256–268
28. Lee GY, Kenny PA, Lee EH, Bissell MJ: Three-dimensional culture
models of normal and malignant breast epithelial cells. Nat Methods
2007, 4:359–365
29. Fu B, Quintero J, Baker CC: Keratinocyte growth conditions modulate
telomerase expression, senescence, and immortalization by human
papillomavirus type 16 E6 and E7 oncogenes. Cancer Res 2003,
63:7815–7824
30. Liu X, Roberts J, Dakic A, Zhang Y, Schlegel R: HPV E7 contributes
to the telomerase activity of immortalized and tumorigenic cells and
augments E6-induced hTERT promoter function. Virology 2008, 375:
611–623
31. Barch MJ, Knutsen T, Spurbeck JL, eds. The AGT Cytogenetics
Laboratory Manual, ed 3. New York, Lippincott-Raven, 1997
32. Shaffer LG TN: ISCN: An International System for Human Cytogenetic
Nomenclature. Basel, S. Karger, 2005
33. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD: MDA-
MB-435 cells are derived from M14 melanoma cells: a loss for breast
cancer, but a boon for melanoma research. Breast Cancer Res Treat
2007, 104:13–19
34. Nakles RE, Shiffert MT, Díaz-Cruz ES, Cabrera MC, Alotaiby M, Mi-
ermont AM, Riegel AT, Furth PA: Altered AIB1 or AIB13 expression
impacts ER effects on mammary gland stromal and epithelial con-
tent. Mol Endocrinol 2011, 25:549–56335. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ:
Expression of the neu protooncogene in the mammary epithelium of
transgenic mice induces metastatic disease. Proc Natl Acad Sci U S
A 1992, 89:10578–10582
36. Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya
T, Takahashi JB, Nishikawa S, Nishikawa S, Muguruma K, Sasai Y: A
ROCK inhibitor permits survival of dissociated human embryonic
stem cells. Nature Biotechnol 2007, 25:681–686
37. Li X, Meng G, Krawetz R, Liu S, Rancourt DE: The ROCK inhibitor
Y-27632 enhances the survival rate of human embryonic stem cells
following cryopreservation. Stem Cells Dev 2008, 17:1079–1085
38. Takehara T, Teramura T, Onodera Y, Kakegawa R, Fukunaga N,
Takenoshita M, Sagawa N, Fukuda K, Hosoi Y: Rho-associated ki-
nase inhibitor Y-27632 promotes survival of cynomolgus monkey
embryonic stem cells. Mol Hum Reprod 2008, 14:627–634
39. Li X, Krawetz R, Liu S, Meng G, Rancourt DE: ROCK inhibitor im-
proves survival of cryopreserved serum/feeder-free single human
embryonic stem cells. Hum Reprod 2009, 24:580–589
40. Hanna JH, Saha K, Jaenisch R: Pluripotency and cellular
reprogramming: facts, hypotheses, unresolved issues. Cell 2010,
143:508–525
41. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingel-
hutz AJ: Both Rb/p16INK4a inactivation and telomerase activity are
required to immortalize human epithelial cells. Nature 1998, 396:
84–88
42. Liu X, Dakic A, Zhang Y, Dai Y, Chen R, Schlegel R: HPV E6 protein
interacts physically and functionally with the cellular telomerase com-
plex. Proc Natl Acad Sci U S A 2009, 106:18780–18785
43. Yue J, Shukla R, Accardi R, Zanella-Cleon I, Siouda M, Cros MP,
Krutovskikh V, Hussain I, Niu Y, Hu S, Becchi M, Jurdic P, Tommasino
M, Sylla BS: Cutaneous HPV 38 E7 regulates actin cytoskeleton
structure for increasing cell proliferation through CK2 and the eukary-
otic elongation factor 1A. J Virol 2011, 85:8477–8494
44. Charette ST, McCance DJ: The E7 protein from human papillomavirus
type 16 enhances keratinocyte migration in an Akt-dependent man-
ner. Oncogene 2007, 26:7386–7390
45. Dong M, Yan BP, Liao JK, Lam YY, Yip GW, Yu CM: Rho-kinase
inhibition: a novel therapeutic target for the treatment of cardiovas-
cular diseases. Drug Discov Today 2010, 15:622–629
46. Wirth A: Rho kinase and hypertension. Biochim Biophys Acta 2010,
1802:1276–1284
47. Pawlak G, Helfman DM: Cytoskeletal changes in cell transformation
and tumorigenesis. Curr Opin Genet Dev 2001, 11:41–47
48. Fridman AL, Tainsky MA: Critical pathways in cellular senescence
and immortalization revealed by gene expression profiling. Onco-
gene 2008, 27:5975–5987
49. Dellambra E, Golisano O, Bondanza S, Siviero E, Lacal P, Molinari M,
D’Atri S, De Luca M: Downregulation of 14-3-3sigma prevents clonal
evolution and leads to immortalization of primary human keratino-
cytes. J Cell Biol 2000, 149:1117–1130
50. Denicourt C, Dowdy SF: Cip/Kip proteins: more than just CDKs inhib-
itors. Genes Dev 2004, 18:851–855
51. Haga K, Ohno S, Yugawa T, Narisawa-Saito M, Fujita M, Sakamoto M,
Galloway DA, Kiyono T: Efficient immortalization of primary human
cells by p16INK4a-specific short hairpin RNA or Bmi-1, combined
with introduction of hTERT. Cancer Sci 2007, 98:147–154
52. Liu X, Disbrow GL, Yuan H, Tomaic V, Schlegel R: Myc and human
papillomavirus type 16 E7 genes cooperate to immortalize human
keratinocytes. J Virol 2007, 81:12689–12695
53. Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, Kruk PA, Cheng
JQ, Bai W, Chen J, Nicosia SV, Zhang X: Deacetylation of cortactin by
SIRT1 promotes cell migration. Oncogene 2009, 28:445–460
54. Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, Quong
JN, Quong AA: Cyclin D1/cyclin-dependent kinase 4 interacts with
filamin A and affects the migration and invasion potential of breast
cancer cells. Cancer Res 2010, 70:2105–2114
